South Dakota House vote

The “Classify medetomidine as a Schedule III controlled substance and establish permissible uses” (HB 1169)

Official title: Classify medetomidine as a Schedule III controlled substance and establish permissible uses.

Passed: 63 yes, 3 no, 4 not voting

Feb 11, 2026 · , HB 1169